Ribbon Biolabs Raises EUR 18 Million Series A Financing
Funds Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology
02-Feb-2022 -
Ribbon Biolabs, the DNA synthesis company, announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed ...
DNA synthesis
Series A financing
synthetic biology
+1